Download PDF
Horm Metab Res 2011; 43(13): 907-910
DOI: 10.1055/s-0031-1295462
Mini-Review
© Georg Thieme Verlag KG Stuttgart · New York

Prevention of Type 2 Diabetes: The Strategic Approach for Implementation

P. E. H Schwarz
1   Division for Prevention and Care of Diabetes Mellitus, Technische Universität Dresden, Dresden, Germany
,
A. L. Albright
2   Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
› Author Affiliations
Further Information

Publication History

received 15 August 2011

accepted 02 November 2011

Publication Date:
07 December 2011 (online)

Also available at
    Permissions and Reprints

Abstract

A growing need exists to deliver effective and affordable prevention programs and to take urgent action to address the major public health challenge that diabetes represents. Achieving prevention of type 2 diabetes requires moving through a series of steps from basic science discovery to widespread distribution of effective interventions. Understanding the cellular level influences on diabetes prevention will help target particular interventions to those who may be most responsive. Several randomized controlled trials conducted throughout the world have demonstrated that type 2 diabetes can be prevented or delayed. Subsequent real-world translation studies have provided important information necessary to reduce cost and increase access. Ultimately achieving a population impact in diabetes prevention requires widespread distribution of effective interventions, which is supported by policies that help achieve sustainability and reach. The use of a global stakeholder network can help to share experiences and build on partner knowledge gained.

Key words

type 2 diabetes - diabetes prevention - visceral fat - public health - global diabetes survey - implementation
 

  • References

  • 1 Schwarz PE, Li J, Reimann M, Schutte AE, Bergmann A, Hanefeld M et al. The Finnish Diabetes Risk Score Is Associated with Insulin Resistance and Progression towards Type 2 Diabetes. J Clin Endocrinol Metab 2009; 94: 920-926
    CrossrefPubMedGoogle Scholar
  • 2 Reimann M, Schutte AE, Schwarz PE. Insulin resistance – the role of ethnicity: evidence from Caucasian and African cohorts. Horm Metab Res 2007; 39: 853-857
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O et al. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res 2006; 38: 178-182
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 1999; 22: 262-270
    CrossrefPubMedGoogle Scholar
  • 5 Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. Association analyses of 249 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948
    CrossrefPubMedGoogle Scholar
  • 6 Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, Dupuis J et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 2010; 59: 1266-1275
    CrossrefPubMedGoogle Scholar
  • 7 Laaksonen DE, Siitonen N, Lindstrom J, Eriksson JG, Reunanen P, Tuomilehto J et al. Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism. Med Sci Sports Exerc 2007; 39: 227-232
    CrossrefPubMedGoogle Scholar
  • 8 Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355: 241-250
    CrossrefPubMedGoogle Scholar
  • 9 Lindstrom J, Peltonen M, Eriksson JG, Aunola S, Hamalainen H, Ilanne-Parikka P et al. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care 2008; 31: 857-862
    CrossrefPubMedGoogle Scholar
  • 10 Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
    CrossrefPubMedGoogle Scholar
  • 11 Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350
    CrossrefPubMedGoogle Scholar
  • 12 Schwarz PE, Reimann M, Li J, Bergmann A, Licinio J, Wong ML et al. The metabolic syndrome – a global challenge for prevention. Horm Metab Res 2007; 39: 777-780
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009; 41: 86-97
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 2007; 66: 101-112
    CrossrefPubMedGoogle Scholar
  • 15 Albright A, Williamson DF. Community Approaches to Diabetes Prevention. In: LeRoith D. (ed) Prevention of Type 2 diabetes; From Science to Therapies. Vol 1. New York: Springer; 2011
    Google Scholar
  • 16 Amundson HA, Butcher MK, Gohdes D, Hall TO, Harwell TS, Helgerson SD et al. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program. Diabetes Educ 2009; 35: 209-210 213–204, 216–220 passim
    CrossrefPubMedGoogle Scholar
  • 17 Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med 2008; 35: 357-363
    CrossrefPubMedGoogle Scholar
  • 18 Kramer MK, Kriska AM, Venditti EM, Miller RG, Brooks MM, Burke LE et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med 2009; 37: 505-511
    CrossrefPubMedGoogle Scholar
  • 19 Schwarz PE, Schwarz J, Schuppenies A, Bornstein SR, Schulze J. Development of a diabetes prevention management program for clinical practice. Public Health Rep 2007; 122: 258-263
    CrossrefPubMedGoogle Scholar
  • 20 Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M et al. The European perspective of type 2 diabetes prevention: diabetes in Europe – prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 2008; 116: 167-172
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N. Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabet Med 2010; 27: 459-465
    CrossrefPubMedGoogle Scholar
  • 22 Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010; 42 (Suppl. 01) S3-S36
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Lindstrom J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U et al. Take action to prevent diabetes – the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010; 42 (Suppl. 01) S37-S55
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Pajunen P, Landgraf R, Muylle F, Neumann A, Lindstrom J, Schwarz PE et al. Quality indicators for the prevention of type 2 diabetes in Europe – IMAGE. Horm Metab Res 2010; 42 (Suppl. 01) S56-S63
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Rothe U, Muller G, Tselmin S, Odenbach C, Scheuch K, Koch R et al. Prevalence for the cluster of risk factors of the Metabolic Vascular Syndrome in a working population in Germany. Horm Metab Res 2009; 41: 168-170
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Rothe U, Muller G, Schwarz PE, Seifert M, Kunath H, Koch R et al. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes Care 2008; 31: 863-868
    CrossrefPubMedGoogle Scholar
  • 27 Schwarz PE, Muylle F, Valensi P, Hall M. The European perspective of diabetes prevention. Horm Metab Res 2008; 40: 511-514
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Onyegbutulem HC, PI HO Reimann M, Li J, Bornstein SR, Schwarz PE. Metabolic syndrome in Africa: an emerging perspective. Horm Metab Res 2009; 41: 75-78
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Sinclair JC, Torrance GW, Boyle MH, Horwood SP, Saigal S, Sackett DL. Evaluation of neonatal-intensive-care programs. N Engl J Med 1981; 305: 489-494
    CrossrefPubMedGoogle Scholar
  • 30 Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147-154
    CrossrefPubMedGoogle Scholar